Skip to content
Smart Today UK

Zimbabwe Turns Down ‘Lopsided’ US Healthcare Assistance Package Over Information Fears

Medical aid image
The offered US funding was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a substantial American healthcare agreement valued at $367m (272 million pounds) spanning five years due to the United States' demand for confidential information.

This rejection became public following a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".

A government spokesperson later stated that the United States was seeking health data for research and commercial gain but was not willing to share the benefits from any future vaccines.

"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for continued talks to reach a agreement agreeable to all parties so the nation's vital HIV programme can continue.

Wider Background

Zimbabwe's decision comes after a similar situation in Kenya, where a court halted a similar health funding agreement after legal challenges were raised about the security of Kenyans' health data.

After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

The agency had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and responsibility.

According to reports, 16 nations in Africa have so far agreed to these new agreements, representing over $18.3bn of fresh investment.

Details of the Declined Deal

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this partnership might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through American-funded programmes," Tremont added.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Our nation was requested to share its genetic material and health information over an extended period, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"Put simply, our country would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our population if a new health crisis emerge."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting structures previously established via the international organization.

The spokesperson cited its Pandemic Benefit-Sharing framework designed to manage future pandemics.

"This mechanism is designed to ensure that when a country contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to develop them."

The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.

"We encourage further discussions with our US partners on how future collaboration might be designed in a manner that honours the sovereignty and interests of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that talks must proceed considering much of the nation's Aids initiatives relied on international support.

"Where specific concerns exist, including those involving information security or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it added.

This impasse emphasises the continuing debate between accepting vital international aid and protecting local interests in an ever more data-driven world.

Written by

Timothy Massey

A tech journalist and business strategist with over a decade of experience covering digital innovations and market trends across Europe.

Smart Today UK

Type to search articles.